LEXINGTON, Massachusetts, July 30, 2018 /PRNewswire/ -- Sekisui Diagnostics announces the FDA clearance of their SEKURE® HbA1c assay. The assay has been cleared to be used as an aid in the diagnosis of diabetes mellitus, as an aid in identification of patients at risk for development...
from PR Newswire: //https://ift.tt/2mWgLhw
No comments:
Post a Comment